DNLI Dividend History & Analysis | 0% Yield

DNLI has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of September 2025, Denali Therapeutics (DNLI) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
ABBV 389,032 M 4.01% 11.1%
GILD 146,242 M 2.91% 5.88%
AMGN 152,211 M 3.34% 4.43%
HLN 44,172 M 1.88% 2.56%
BIOG-B 1,118 M 1.87% 1.80%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (CAGR) Payout Consistency
BIOG-B 1,118 M 20.4% 92.8%
GRFS 8,687 M 50.6% 60.7%
SECARE 679 M 10.4% 100%
AMGN 152,211 M 7.06% 100%
ABBV 389,032 M 5.61% 100%

Similar Stocks with Attractive Dividends - Compare DNLI Dividends with its Peer-Group

ABBV
AbbVie
4.01% Yield
AMGN
Amgen
3.34% Yield
GILD
Gilead Sciences
2.91% Yield
VOX
Voxel S.A.
1.80% Yield

DNLI Dividend History: as of September 2025

No dividends paid yet.

DNLI Dividend FAQ

Denali Therapeutics Inc (NASDAQ:DNLI) is a biotechnology company listed on the NASDAQ stock exchange, operating in the biotechnology sub-industry. The companys stock is classified as a common stock and is of US origin.

What is the Dividend Yield of DNLI?

As of September 2025, DNLI`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 13.16.

Does DNLI pay a dividend?

As of September 2025 DNLI does not pay a dividend.

How often does DNLI pay dividends?

Over the last 12 months, DNLI has issued dividend payments.

Will DNLI pay dividends in 2025?

The next Ex-Dividend date for Denali Therapeutics (DNLI) is currently unknown.

What is the next Ex-Dividend Date for DNLI?

The next Ex-Dividend date for Denali Therapeutics (DNLI) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of DNLI?

DNLI's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of DNLI?

DNLI's 5-Year Yield on Cost is -%. If you bought DNLI's shares at 38.84 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of DNLI?

DNLI Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does DNLI have a good Dividend Yield?

DNLI`s 0.00% Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of DNLI?

The Dividend Payout Ratio of DNLI is unknown.

What is the Dividend Rating of DNLI?

DNLI`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

DNLI Outstanding Shares Analysis

What is the Trend in DNLI`s Outstanding Shares (CAGR)?

Denali Therapeutics`s outstanding shares have increased by approximately 3.03% annually over the past 3 years (Correlation: 93.9%), negatively influencing the share price.

Has Denali Therapeutics ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2015 3,000,000
2016 9,017,400 +200.58%
2017 30,744,000 +240.94%
2018 97,746,200 +217.94%
2019 96,079,000 -1.71%
2020 128,297,800 +33.53%
2021 122,164,600 -4.78%
2022 132,877,400 +8.77%
2023 138,245,400 +4.04%
2024 170,086,100 +23.03%
2025 171,449,800 +0.8%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid in the last 12m (TTM).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.

Last update: 2025-09-11 04:03